Transcriptomics Market Trends 2025–2029: Forecasts for Key Growth Segments

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Transcriptomics Industry Compare Between 2025 And 2029?

The transcriptomics market has experienced robust expansion in recent years. It is projected to increase from $6.51 billion in 2024 to $7.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be attributed to an escalating focus on personalized medicine, a rising prevalence of cancer, the integration of genomics into clinical diagnostics, the broader application of ribonucleic acid sequencing, and the ongoing demand for biomarker discovery.

The transcriptomics market is set to experience significant expansion over the next few years, with its size projected to reach $9.57 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is fueled by several factors, including the increasing adoption of single-cell ribonucleic acid sequencing, the growing integration of spatial transcriptomics, the rising demand for multiomics approaches, an intensified focus on early disease detection, and a heightened understanding of the importance of non-coding ribonucleic acids. Prominent trends expected in this period include advancements in next-generation sequencing (NGS) technologies, technological improvements in spatial transcriptomics, developments in bioinformatics tools, the integration of machine learning into transcriptomics, and technological progress in real-time transcriptomic analysis.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Major Market Drivers Are Shaping The Future Of The Transcriptomics Market?

Future expansion of the transcriptomics market is anticipated to be driven by the rising acceptance of personalized medicine. This approach involves tailoring medical treatments to an individual’s unique genetic makeup, lifestyle choices, and environmental factors. Its expansion is fueled by breakthroughs in genetic sequencing, allowing the development of more effective therapies precisely matched to individual genetic profiles. Transcriptomics plays a crucial role by revealing specific gene expression profiles for individuals, thereby informing personalized treatment strategies derived from a patient’s distinct biological characteristics. This technology contributes to improved treatment efficacy, reduced adverse reactions, and earlier identification of diseases. As an illustration, the Personalized Medicine Coalition, a US-based hospital and health care entity, reported in February 2024 that the FDA cleared 16 new personalized therapies for individuals with rare diseases in 2023, a notable increase from six approvals recorded in 2022. Consequently, the increasing adoption of personalized medicine serves as a key driver for the growth of the transcriptomics market.

What Are The Key Segments In The Transcriptomics Market?

The transcriptomicsmarket covered in this report is segmented –

1) By Type: Instruments; Consumables; Software; Services

2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications

4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments

2) By Consumables: Reagents; Probes; Kits; Chips

3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services

What Long-Term Trends Will Shape The Future Growth Of The Transcriptomics Industry?

Leading companies in the transcriptomics market are concentrating on developing advanced products like single-cell spatial panels to gain deeper insights into cellular functions and disease mechanisms. These single-cell spatial panels analyze gene expression at the individual cell level while preserving each cell’s original position within the tissue. They integrate single-cell transcriptomics with spatial data, offering comprehensive views of both cellular activity and tissue architecture. For example, in February 2024, NanoString Technologies, a US-based biotechnology company, launched the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay. This launch signifies the commercial availability of the industry’s initial single-cell spatial panel capable of quantifying over 6,000 RNA targets across nearly all human biological pathways. This innovation, designed for use with the CosMx Spatial Molecular Imager (SMI), allows researchers to profile genes with high accuracy and advanced cell segmentation at single-cell and subcellular resolution.

Who Are The Top Performing Companies In The Transcriptomics Market In Recent Years?

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Transcriptomics Market?

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Transcriptomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Browse Through More Reports Similar to the Global Transcriptomics Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense Rnai Therapeutics Market 2025

https://www.thebusinessresearchcompany.com/report/antisense-rnai-therapeutics-market

Dna Or Rna Sample Extraction And Isolation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-or-rna-sample-extraction-and-isolation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795